Home › Public scrutiny of $4 bn Sun Pharma-Ranbaxy Laboratories deal starts
 

Keywords :   


Public scrutiny of $4 bn Sun Pharma-Ranbaxy Laboratories deal starts

2014-09-04 11:58:29| Chemicals - Topix.net

CCI had asked the Sun Pharma and Ranbaxy on August 27 to make public specific details of their proposed merger. In the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today invited comments from all stakeholders, including general public, on finer details of USD 4-billion merger of Ranbaxy Laboratories Ltd into rival drugmaker Sun Pharmaceutical Industries .

Tags: public sun deal starts

Category:Chemicals

Latest from this category

All news
28.06Jotun Launches CX-Rated Anticorrosive Powder Coating
28.06RPM to Announce Fiscal 2024 4Q, Year-End Results
28.06Evonik Commissions New Plant for AEROSIL Silicas
28.06BCFs Coatings Ambassador Program Trains Its 50th Ambassador
28.06Global Green Building Alliance Launches Guide to Net Zero
27.06Nippon Paint Marines FASTAR Coating Honored by JCIA
27.06Jeremy Sukola Named VP of Prime Resins
27.06CalPoly Hosts Polymers & Coatings Summer 2024 Short Course
Chemicals »
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »